Six patients with relapsed acute promyelocytic leukemia (APL) received autologous stem cell transplantation (ASCT) in second (n=5) or fourth (n=1) molecular remission with a molecularly negative graft. After a median follow-up of 33 months from ASCT, 5 patients are alive in molecular remission and one died 27 months after autograft from refractory relapse.
Prolonged molecular remission after autologous stem cell transplantation in relapsed acute promyelocytic leukemia / Ferrara, Felicetto; Palmieri, Salvatore; Annunziata, Mario; Pocali, Barbara; Viola, Assunta; Pane, Fabrizio. - In: HAEMATOLOGICA. - ISSN 1592-8721. - 89:5(2004), pp. 621-622.
Prolonged molecular remission after autologous stem cell transplantation in relapsed acute promyelocytic leukemia
PANE, FABRIZIO
2004
Abstract
Six patients with relapsed acute promyelocytic leukemia (APL) received autologous stem cell transplantation (ASCT) in second (n=5) or fourth (n=1) molecular remission with a molecularly negative graft. After a median follow-up of 33 months from ASCT, 5 patients are alive in molecular remission and one died 27 months after autograft from refractory relapse.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
